Instil Bio's market cap is currently ―. The company's EPS TTM is $-23.998; its P/E ratio is -0.45; Instil Bio is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-2.23. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	-	-	-	$ 0.00	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -18.07M	$ -58.45M	$ -56.80M	$ -55.79M	$ -59.27M
EBITDA	-	$ -56.40M	$ -53.49M	$ -53.85M	$ -58.22M
Net Income Common Stockholders	$ -18.66M	$ -57.07M	$ -53.84M	$ -56.22M	$ -58.99M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 201.70M	$ 223.19M	$ 260.92M	$ 303.29M	$ 354.61M
Total Assets	$ 408.31M	$ 427.17M	$ 482.13M	$ 532.74M	$ 568.54M
Total Debt	$ 85.21M	$ 81.25M	$ 77.52M	$ 70.88M	$ 57.13M
Net Debt	$ -116.48M	$ -141.95M	$ -183.40M	$ -232.41M	$ -297.47M
Total Liabilities	$ 111.79M	$ 116.02M	$ 118.52M	$ 122.15M	$ 110.20M
Stockholders Equity	$ 296.52M	$ 311.15M	$ 363.61M	$ 410.59M	$ 458.33M
Cash Flow	-
Free Cash Flow	-	$ -42.89M	$ -49.99M	$ -66.08M	$ -73.40M
Operating Cash Flow	$ -19.56M	$ -34.43M	$ -36.98M	$ -40.88M	$ -47.26M
Investing Cash Flow	$ 10.33M	$ 14.29M	$ 32.80M	$ 25.37M	$ -21.50M
Financing Cash Flow	$ 4.20M	$ 4.47M	$ 6.20M	$ 14.72M	$ 50.62M

Currency in USD

Instil Bio Earnings and Revenue History

Income Statement >

Instil Bio Debt to Assets

Balance Sheet >

Instil Bio Cash Flow

Cash Flow >

Instil Bio Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing